(1)連結損益計算書

(単位:百万円)

 

 

前年度

(自  2024年4月1日

  至  2025年3月31日)

当年度

(自  2025年4月1日

  至  2026年3月31日)

売上収益

 

4,581,551

4,505,720

売上原価

 

1,580,217

1,571,588

販売費及び一般管理費

 

1,104,766

1,084,215

研究開発費

 

730,227

675,924

製品に係る無形資産償却費及び減損損失

 

643,233

633,544

その他の営業収益

 

26,212

24,747

その他の営業費用

 

206,733

156,435

営業利益

 

342,586

408,761

 

 

 

 

金融収益

 

46,549

211,177

金融費用

 

210,065

357,572

持分法による投資損益

 

3,986

2,177

税引前当期利益

 

175,084

260,189

法人所得税費用

 

66,941

68,163

当期利益

 

108,143

192,026

 

 

 

 

 

 

 

 

当期利益の帰属

 

 

 

親会社の所有者持分

 

107,928

191,762

非支配持分

 

215

264

合計

 

108,143

192,026

 

 

 

 

 

 

 

 

1株当たり当期利益(円)

 

 

 

基本的1株当たり当期利益

 

68.36

121.75

希薄化後1株当たり当期利益

 

67.23

119.64

 

 

 

 

 

E00919 45020 武田薬品工業株式会社 Takeda Pharmaceutical Company Limited 通期第3号参考様式 [IFRS](連結) IFRS true cte cte 2025-04-01 2026-03-31 FY 2026-03-31 2024-04-01 2025-03-31 2025-03-31 1 false false false 45020 2026-05-13 45020 2025-04-01 2026-03-31 45020 2025-04-01 2026-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2025-04-01 2026-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2025-04-01 2026-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2025-04-01 2026-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2025-04-01 2026-03-31 tse-acediffr-45020:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 45020 2026-03-31 45020 2026-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2026-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2026-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2026-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2026-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2026-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2026-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2026-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2026-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2026-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2026-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2026-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2026-03-31 tse-acediffr-45020:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 45020 2024-04-01 2025-03-31 45020 2024-04-01 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2024-04-01 2025-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2024-04-01 2025-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2024-04-01 2025-03-31 tse-acediffr-45020:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 45020 2025-03-31 45020 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2025-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2025-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2025-03-31 tse-acediffr-45020:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 45020 2024-03-31 45020 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2024-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2024-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2024-03-31 tse-acediffr-45020:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure